ZTS RSI Chart
Last 7 days
5.8%
Last 30 days
1.6%
Last 90 days
-14.5%
Trailing 12 Months
-8.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 8.7B | 0 | 0 | 0 |
2023 | 8.1B | 8.2B | 8.4B | 8.5B |
2022 | 7.9B | 8.0B | 8.0B | 8.1B |
2021 | 7.0B | 7.4B | 7.6B | 7.8B |
2020 | 6.3B | 6.3B | 6.5B | 6.7B |
2019 | 5.9B | 6.0B | 6.2B | 6.3B |
2018 | 5.4B | 5.6B | 5.7B | 5.8B |
2017 | 5.0B | 5.0B | 5.1B | 5.3B |
2016 | 4.8B | 4.9B | 4.9B | 4.9B |
2015 | 4.8B | 4.8B | 4.8B | 4.8B |
2014 | 4.6B | 4.6B | 4.7B | 4.8B |
2013 | 4.4B | 4.4B | 4.5B | 4.6B |
2012 | 4.3B | 4.3B | 4.3B | 4.3B |
2011 | 3.7B | 3.9B | 4.1B | 4.2B |
2010 | 0 | 0 | 0 | 3.6B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index
Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.
Returns of $10,000 invested in:
Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022
Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 18, 2024 | lagano roxanne | sold | -139,530 | 151 | -923 | executive vice president |
Mar 18, 2024 | lagano roxanne | sold | -319,967 | 173 | -1,846 | executive vice president |
Mar 11, 2024 | reed willie m | sold | -250,265 | 182 | -1,370 | - |
Feb 21, 2024 | norden gregory | gifted | - | - | -2,214 | - |
Feb 20, 2024 | lagano roxanne | sold | -172,878 | 187 | -923 | executive vice president |
Feb 20, 2024 | peck kristin c | acquired | 599,170 | 46.09 | 13,000 | chief executive officer |
Feb 20, 2024 | peck kristin c | sold | -2,433,640 | 187 | -13,000 | chief executive officer |
Feb 13, 2024 | lagano roxanne | sold | -532,177 | 186 | -2,848 | executive vice president |
Feb 12, 2024 | lagano roxanne | sold | -71,779 | 197 | -363 | executive vice president |
Feb 10, 2024 | reed willie m | acquired | - | - | 1,463 | - |
Which funds bought or sold ZTS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 06, 2024 | GREAT VALLEY ADVISOR GROUP, INC. | added | 6.94 | -389,888 | 4,295,570 | 0.13% |
May 06, 2024 | HighTower Advisors, LLC | added | 0.62 | -10,950,000 | 68,609,000 | 0.11% |
May 06, 2024 | Wealthspire Advisors, LLC | reduced | -9.43 | -211,480 | 734,729 | 0.01% |
May 06, 2024 | Bard Financial Services, Inc. | unchanged | - | -65,472 | 393,413 | 0.04% |
May 06, 2024 | NEW YORK LIFE INVESTMENT MANAGEMENT LLC | reduced | -3.28 | -2,436,090 | 11,829,800 | 0.12% |
May 06, 2024 | BANQUE PICTET & CIE SA | added | 0.42 | -68,168,300 | 422,008,000 | 3.96% |
May 06, 2024 | Advisory Alpha, LLC | added | 28.67 | 34,727 | 372,158 | 0.01% |
May 06, 2024 | Hartford Funds Management Co LLC | added | 10.41 | -15,529 | 276,316 | 0.03% |
May 06, 2024 | Carnegie Capital Asset Management, LLC | added | 3.35 | -3,914,460 | 30,439,800 | 0.95% |
May 06, 2024 | Cohen Capital Management, Inc. | added | 5.38 | -216,764 | 2,028,320 | 0.36% |
Unveiling Zoetis Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Zoetis Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 357.8B | 85.6B | 9.3 | 4.18 | ||||
MRK | 330.2B | 61.4B | 143.19 | 5.38 | ||||
AMGN | 161.1B | 29.5B | 42.82 | 5.46 | ||||
PFE | 156.8B | 46.5B | -112.94 | 3.37 | ||||
GILD | 81.5B | 27.1B | 14.39 | 3.01 | ||||
TEVA | 15.6B | 15.8B | -27.14 | 0.99 | ||||
MID-CAP | ||||||||
ALKS | 4.2B | 1.7B | 9.58 | 2.41 | ||||
PRGO | 4.1B | 4.6B | -533.77 | 0.9 | ||||
BHC | 2.7B | 9.0B | -5.97 | 0.3 | ||||
AMPH | 2.1B | 644.4M | 14.96 | 3.19 | ||||
SMALL-CAP | ||||||||
TLRY | 1.5B | 743.2M | -4.38 | 2.07 | ||||
TXMD | 23.2M | 1.3M | -2.26 | 17.8 | ||||
ACRX | 17.0M | - | -0.92 | 0.22 | ||||
AGRX | 2.7M | 19.6M | -0.19 | 0.14 | ||||
ACOR | 1.1M | 117.6M | 0 | 0.01 |
Zoetis Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -1.0% | 2,190 | 2,213 | 2,151 | 2,180 | 2,000 | 2,040 | 2,002 | 2,052 | 1,986 | 1,967 | 1,990 | 1,948 | 1,871 | 1,807 | 1,786 | 1,548 | 1,534 | 1,674 | 1,584 | 1,547 | 1,455 |
S&GA Expenses | -3.2% | 547 | 565 | 525 | 556 | 505 | 514 | 501 | 529 | 465 | 593 | 504 | 495 | 409 | 520 | 424 | 393 | 389 | 472 | 391 | 406 | 369 |
EBITDA Margin | -0.5% | 0.43* | 0.43* | 0.43* | 0.43* | 0.41* | 0.41* | 0.41* | 0.40* | 0.41* | 0.41* | 0.40* | 0.41* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 15.3% | 68.00 | 59.00 | 59.00 | 58.00 | 63.00 | 62.00 | 53.00 | 53.00 | 53.00 | 54.00 | 56.00 | 57.00 | 57.00 | 58.00 | 62.00 | 58.00 | 53.00 | 56.00 | 56.00 | 55.00 | 56.00 |
Income Taxes | 16.5% | 148 | 127 | 121 | 202 | 146 | 132 | 139 | 141 | 133 | 93.00 | 107 | 125 | 129 | 62.00 | 118 | 106 | 74.00 | 53.00 | 95.00 | 84.00 | 69.00 |
Earnings Before Taxes | 14.9% | 747 | 650 | 717 | 872 | 697 | 592 | 667 | 670 | 727 | 506 | 659 | 636 | 687 | 420 | 597 | 482 | 497 | 437 | 528 | 455 | 381 |
EBT Margin | -0.5% | 0.34* | 0.34* | 0.34* | 0.34* | 0.32* | 0.33* | 0.32* | 0.32* | 0.32* | 0.32* | 0.32* | 0.32* | - | - | - | - | - | - | - | - | - |
Net Income | 14.1% | 599 | 525 | 596 | 671 | 552 | 461 | 529 | 529 | 595 | 414 | 552 | 512 | 559 | 359 | 479 | 377 | 423 | 384 | 433 | 371 | 312 |
Net Income Margin | -0.2% | 0.27* | 0.27* | 0.27* | 0.27* | 0.26* | 0.26* | 0.26* | 0.26* | 0.26* | 0.26* | 0.26* | 0.26* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -34.9% | 455 | 699 | 579 | 17.00 | 326 | 570 | 372 | 190 | 194 | 511 | 534 | 368 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 0.4% | 14,348 | 14,286 | 14,106 | 13,749 | 13,754 | 14,900 | 13,674 | 13,770 | 13,860 | 13,900 | 13,705 | 14,069 | 13,796 | 13,600 | 13,725 | 13,069 | 11,528 | 11,545 | 11,272 | 10,986 | 10,883 |
Current Assets | 0.3% | 6,359 | 6,343 | 6,222 | 6,183 | 6,269 | 7,506 | 6,551 | 6,651 | 6,837 | 6,930 | 6,682 | 7,048 | 6,794 | 6,611 | 6,757 | 6,285 | 4,772 | 4,748 | 4,618 | 4,484 | 4,379 |
Cash Equivalents | -3.2% | 1,975 | 2,041 | 1,754 | 1,717 | 2,109 | 3,581 | 2,507 | 2,652 | 3,135 | 3,485 | 3,274 | 3,658 | 3,602 | 3,604 | 3,654 | 3,353 | 1,951 | 1,934 | 1,815 | 1,755 | 1,728 |
Inventory | 3.4% | 2,651 | 2,564 | 2,744 | 2,701 | 2,563 | 2,345 | 2,303 | 2,205 | 2,057 | 1,923 | 1,875 | 1,802 | 1,700 | 1,628 | 1,626 | 1,584 | 1,481 | 1,410 | 1,439 | 1,404 | 1,361 |
Net PPE | 1.5% | 3,251 | 3,204 | 3,092 | 3,011 | 2,913 | 2,753 | 2,623 | 2,559 | 2,487 | 2,422 | 2,338 | 2,286 | 2,227 | 2,202 | 2,099 | 2,011 | 1,977 | 1,940 | 1,813 | 1,739 | 1,683 |
Goodwill | 0% | 2,759 | 2,759 | 2,762 | 2,714 | 2,738 | 2,746 | 2,692 | 2,720 | 2,685 | 2,682 | 2,703 | 2,718 | 2,707 | 2,694 | 2,690 | 2,629 | 2,583 | 2,592 | 2,550 | 2,505 | 2,522 |
Liabilities | 0.0% | 9,296 | 9,295 | 9,032 | 9,128 | 9,263 | 10,522 | 9,012 | 9,190 | 9,202 | 9,356 | 9,024 | 9,717 | 9,704 | 9,836 | 10,118 | 10,082 | 8,775 | 8,837 | 8,594 | 8,575 | 8,566 |
Current Liabilities | 1.1% | 1,909 | 1,889 | 1,608 | 1,769 | 1,915 | 3,167 | 2,880 | 3,051 | 3,034 | 1,797 | 1,471 | 2,091 | 2,066 | 2,170 | 2,400 | 1,811 | 1,721 | 1,806 | 1,052 | 1,075 | 1,082 |
Short Term Borrowings | 700.0% | 24.00 | 3.00 | 2.00 | 2.00 | 3.00 | 2.00 | 3.00 | 2.00 | - | - | - | 4.00 | 4.00 | 4.00 | 1.00 | 1.00 | - | - | - | - | - |
Long Term Debt | 0.0% | 6,562 | 6,564 | 6,552 | 6,555 | 6,559 | 6,552 | 5,210 | 5,221 | 5,228 | 6,592 | 6,592 | 6,592 | 6,587 | 6,595 | 6,595 | 7,194 | 5,963 | 5,947 | 6,447 | 6,446 | 6,444 |
LT Debt, Current | - | - | - | - | - | - | 1,350 | 1,350 | 1,350 | 1,350 | - | - | 600 | 600 | 600 | 1,100 | 500 | - | 500 | - | - | - |
LT Debt, Non Current | -100.0% | - | 6,564 | 6,552 | 6,555 | 6,559 | 6,552 | 5,210 | 5,221 | 5,228 | 6,592 | 6,592 | 6,592 | 6,587 | 6,595 | 6,595 | 7,194 | 5,963 | 5,947 | 6,447 | 6,446 | 6,444 |
Shareholder's Equity | 1.1% | 5,052 | 4,997 | 5,078 | 4,621 | 4,491 | 4,405 | 4,662 | 4,580 | 4,658 | 4,544 | 4,681 | 4,352 | 4,092 | 3,773 | 3,607 | 2,987 | 2,753 | 2,708 | 2,678 | 2,411 | 2,317 |
Retained Earnings | 3.9% | 10,696 | 10,295 | 10,140 | 9,543 | 9,045 | 8,668 | 8,533 | 8,004 | 7,628 | 7,186 | 7,044 | 6,492 | 6,099 | 5,659 | 5,526 | 5,048 | 4,764 | 4,427 | 4,217 | 3,788 | 3,495 |
Additional Paid-In Capital | -0.6% | 1,126 | 1,133 | 1,116 | 1,098 | 1,079 | 1,088 | 1,073 | 1,059 | 1,046 | 1,068 | 1,056 | 1,044 | 1,030 | 1,065 | 1,040 | 1,030 | 1,017 | 1,044 | 1,031 | 1,019 | 1,008 |
Accumulated Depreciation | 3.0% | 2,673 | 2,594 | 2,529 | 2,447 | 2,374 | 2,297 | 2,232 | 2,193 | 2,141 | 2,072 | 2,113 | 2,064 | 2,012 | 1,952 | 1,894 | 1,818 | 1,769 | 1,737 | 1,725 | 1,685 | 1,642 |
Shares Outstanding | -0.3% | 457 | 458 | 460 | 461 | 462 | 464 | 468 | 470 | 472 | 474 | 475 | 475 | - | - | - | - | - | - | - | - | - |
Minority Interest | 0% | -6.00 | -6.00 | -4.00 | -4.00 | -3.00 | -2.00 | -1.00 | - | - | 1.00 | 2.00 | 2.00 | 3.00 | 4.00 | 5.00 | 5.00 | - | - | - | - | - |
Float | - | - | - | - | 79,346 | - | - | - | 80,550 | - | - | - | 88,374 | - | - | - | 65,094 | - | - | - | 54,228 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -33.7% | 595 | 897 | 724 | 183 | 549 | 741 | 526 | 336 | 309 | 679 | 653 | 481 | 400 | 718 | 562 | 438 | 408 | 582 | 506 | 318 | 389 |
Share Based Compensation | 5.9% | 18.00 | 17.00 | 17.00 | 17.00 | 9.00 | 16.00 | 15.00 | 15.00 | 16.00 | 14.00 | 15.00 | 16.00 | 13.00 | 13.00 | 14.00 | 16.00 | 16.00 | 16.00 | 16.00 | 17.00 | 18.00 |
Cashflow From Investing | 37.6% | -131 | -210 | -271 | -80.00 | -216 | -438 | -124 | -203 | -118 | -142 | -114 | -139 | -63.00 | -177 | -174 | -164 | -57.00 | -213 | -209 | -59.00 | -23.00 |
Cashflow From Financing | -32.0% | -524 | -397 | -416 | -494 | -1,802 | 780 | -529 | -610 | -545 | -314 | -919 | -290 | -339 | -597 | -93.00 | 1,141 | -328 | -250 | -232 | -226 | -243 |
Buy Backs | 44.3% | 339 | 235 | 250 | 324 | 283 | 405 | 377 | 451 | 361 | 198 | 198 | 166 | 181 | - | - | - | 250 | 176 | 150 | 150 | 150 |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |||
Income Statement [Abstract] | ||||
Revenue | $ 2,190 | $ 2,000 | ||
Costs and expenses: | ||||
Cost of sales | 643 | 588 | ||
Selling, general and administrative expenses | 547 | 505 | ||
Research and development expenses | 162 | 142 | ||
Amortization of intangible assets | 37 | 37 | ||
Restructuring charges and certain acquisition-related costs | 4 | 21 | ||
Interest expense, net of capitalized interest | 58 | 63 | ||
Other (income)/deductions—net | (8) | (53) | ||
Income before provision for taxes on income | [1] | 747 | 697 | |
Provision for taxes on income | 148 | 146 | ||
Net income before allocation to noncontrolling interests | 599 | 551 | ||
Less: Net loss attributable to noncontrolling interests | 0 | (1) | ||
Net income attributable to Zoetis Inc. | $ 599 | $ 552 | ||
Earnings per share attributable to Zoetis Inc. stockholders: | ||||
Basic (in dollars per share) | $ 1.31 | $ 1.19 | ||
Diluted (in dollars per share) | $ 1.31 | $ 1.19 | ||
Weighted-average common shares outstanding: | ||||
Basic (in shares) | 458.0 | 463.5 | ||
Diluted (in shares) | 458.8 | 464.6 | ||
Dividends paid per common share (in dollars per share) | $ 0.432 | $ 0.375 | ||
|
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 | ||
---|---|---|---|---|
Assets | ||||
Cash and cash equivalents | [1] | $ 1,975 | $ 2,041 | |
Accounts receivable, less allowance for doubtful accounts of $20 in 2024 and $18 in 2023 | 1,293 | 1,304 | ||
Inventories | 2,651 | 2,564 | ||
Other current assets | 440 | 434 | ||
Total current assets | 6,359 | 6,343 | ||
Property, plant and equipment, less accumulated depreciation of $2,673 in 2024 and $2,594 in 2023 | 3,251 | 3,204 | ||
Operating lease right of use assets | 225 | 230 | ||
Goodwill | 2,759 | 2,759 | ||
Identifiable intangible assets, less accumulated amortization | 1,295 | 1,338 | ||
Noncurrent deferred tax assets | 232 | 206 | ||
Other noncurrent assets | 227 | 206 | ||
Total assets | 14,348 | 14,286 | ||
Liabilities and Equity | ||||
Short-term borrowings | 24 | 3 | ||
Accounts payable | 405 | 411 | ||
Dividends payable | 198 | 198 | ||
Accrued expenses | 691 | 683 | ||
Accrued compensation and related items | 272 | 382 | ||
Income taxes payable | 230 | 110 | ||
Other current liabilities | 89 | 102 | ||
Total current liabilities | 1,909 | 1,889 | ||
Long-term debt, net of discount and issuance costs | 6,562 | 6,564 | ||
Noncurrent deferred tax liabilities | 136 | 146 | ||
Operating lease liabilities | 184 | 188 | ||
Other taxes payable | 277 | 271 | ||
Other noncurrent liabilities | 228 | 237 | ||
Total liabilities | 9,296 | 9,295 | ||
Commitments and contingencies (Note 15) | ||||
Stockholders’ equity: | ||||
Common stock, $0.01 par value: 6,000,000,000 authorized; 501,891,243 and 501,891,243 shares issued; 456,947,205 and 458,367,358 shares outstanding at March 31, 2024, and December 31, 2023, respectively | 5 | 5 | ||
Treasury stock, at cost, 44,944,038 and 43,523,885 shares of common stock at March 31, 2024 and December 31, 2023, respectively | (5,928) | (5,597) | ||
Additional paid-in capital | 1,126 | 1,133 | ||
Retained earnings | 10,696 | 10,295 | ||
Accumulated other comprehensive loss | (841) | (839) | ||
Total Zoetis Inc. equity | 5,058 | 4,997 | ||
Equity attributable to noncontrolling interests | (6) | (6) | ||
Total equity | 5,052 | 4,991 | ||
Total liabilities and equity | $ 14,348 | $ 14,286 | ||
|
 | Ms. Kristin C. Peck |
---|---|
 | zoetis.com |
 | Pharmaceuticals |
 | 13800 |